[Federal Register: September 10, 1999 (Volume 64, Number 175)]
[Notices]               
[Page 49201]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr10se99-123]                         

-----------------------------------------------------------------------

DEPARTMENT OF HEALTH AND HUMAN SERVICES

National Institutes of Health

 
National Cancer Institute; Notice of Meeting

    Pursuant to section 10(d) of the Federal Advisory Committee Act, as 
amended (5 U.S.C. Appendix 2) notice is hereby given of the meeting of 
the National Cancer Advisory Board.
    The meeting will be open to the public as indicated below, with 
attendance limited to space available. Individuals who plan to attend 
and need special assistance, such as sign language interpretation or 
other reasonable accommodations, should notify the Contact Person 
listed below in advance of the meeting.
    The meeting will be closed to the public in accordance with the 
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5 
U.S.C., as amended. The grant applications and/or contract proposals 
and the discussions could disclose confidential trade secrets or 
commercial property such as patentable material, and personal 
information concerning individuals associated with the grant 
applications and/or contract proposals, the disclosure of which would 
constitute a clearly unwarranted invasion of personal privacy.

    Name of Committee: National Cancer Advisory Board.
    Dates: September 22-24, 1999.
    Name of Committee: National Cancer Advisory Board, Subcommittee 
on Activities and Agenda.
    Closed: September 22, 7:30 p.m.--Recess.
    Agenda: To discuss activities related to methodologies for 
transmission and evaluation of confidential grant information, 
including demonstrations using live data.
    Place: The Hyatt Regency Hotel, One Bethesda Metro Center, 
Bethesda, MD 20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, NIH, Executive Blvd., MSC 7405, Bethesda, 
MD 20892-7405, (301) 496-5147.

    Name of Committee: National Cancer Advisory Board.
    Dates: September 23-24, 1999.
    Open: September 23, 9:00 a.m. to 3:30 p.m.; September 24, 9:00 
to 11:15 a.m.
    Agenda: Program reports and presentations; business of the 
Board. For detailed agenda: See NCI Homepage/Advisory Board and 
Groups, http://deainfor/nci.nih.gov/ADVISORY/boards.htm; Tentative 
agenda available 10 working days prior to meetings; Final agenda 
available 5 working days prior to meetings.
    Closed: September 23, 3:45 p.m. to Recess.
    Agenda: To review and evaluate grant applications.
    Place: Building 31C, Conference Room 10, National Institutes of 
Health, 3100 Center Drive, Bethesda, MD 20892.
    Contact Person: Dr. Marvin R. Kalt, Executive Secretary, 
National Cancer Institute, National Institutes of Health, Executive 
Plaza North, Suite 600, 6130 Executive Boulevard, Rockville, MD 
20892, (301) 496-5147.

(Catalogue of Federal Domestic Assistance Program Nos. 93.392, 
Cancer Construction; 93.393, Cancer Cause and Prevention Research; 
93.394, Cancer Detection and Diagnosis Research; 93.395, Cancer 
Treatment Research; 93.396, Cancer Biology Research; 93.397, Cancer 
Centers Support; 93.398, Cancer Research Manpower; 93.399, Cancer 
Control, National Institutes of Health, HHS)

    Dated August 31, 1990.
LaVerne Y. Stringfield,
Committee Management Officer, NIH.
[FR Doc. 99-23562 Filed 9-9-99; 8:45 am]
BILLING CODE 4140-01-M